201 related articles for article (PubMed ID: 1735693)
21. Chloronitroimidazoles as radiosensitizers of hypoxic cells in vitro.
Wideł M; Watras J; Suwiński J; Salwińska E
Neoplasma; 1987; 34(3):241-51. PubMed ID: 3614460
[TBL] [Abstract][Full Text] [Related]
22. Radiosensitizing ability and cytotoxicity of some 5(4)-substituted 2-methyl-4(5)-nitroimidazoles.
Wideł M; Watras J; Suwiński J; Salwińska E
Neoplasma; 1982; 29(4):407-15. PubMed ID: 7133232
[TBL] [Abstract][Full Text] [Related]
23. Multicellular membranes as an in vitro model for extravascular diffusion in tumours.
Cowan DS; Hicks KO; Wilson WR
Br J Cancer Suppl; 1996 Jul; 27():S28-31. PubMed ID: 8763841
[TBL] [Abstract][Full Text] [Related]
24. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
Papadopoulou MV; Bloomer WD
Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
[TBL] [Abstract][Full Text] [Related]
25. Radiosensitization by metal complexes of 4(5)-nitroimidazole.
Skov KA; Farrell NP
Int J Radiat Biol; 1990 May; 57(5):947-58. PubMed ID: 1970996
[TBL] [Abstract][Full Text] [Related]
26. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents.
Astor M; Hall EJ; Biaglow JE; Parham JC
Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):75-83. PubMed ID: 7061257
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro.
Stratford IJ; Williamson C; Hardy C
Br J Cancer; 1981 Jul; 44(1):109-16. PubMed ID: 7259957
[TBL] [Abstract][Full Text] [Related]
28. Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitro.
Millar BC; Jinks S; Powles TJ
Br J Cancer; 1981 Nov; 44(5):733-40. PubMed ID: 7317272
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo radiosensitizing effects of 2-nitroimidazole derivatives with sugar component.
Murayama C; Tanaka N; Miyamoto Y; Sakaguchi M; Mori T
Strahlenther Onkol; 1987 Jun; 163(6):385-90. PubMed ID: 3603366
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-specific inhibition of recovery from radiation damage by a novel 2-nitroimidazole with a theophylline side chain.
Hodgkiss RJ; Kelleher E; Parrick J
Int J Radiat Biol; 1992 Jun; 61(6):797-803. PubMed ID: 1351530
[TBL] [Abstract][Full Text] [Related]
31. Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole.
Born JL; Smith BR; Harper N; Koch CJ
Biochem Pharmacol; 1992 Mar; 43(6):1337-44. PubMed ID: 1562284
[TBL] [Abstract][Full Text] [Related]
32. Iodinated nitroimidazoles as radiosensitizers.
Krause W; Jordan A; Scholz R; Jimenez JL
Anticancer Res; 2005; 25(3B):2145-51. PubMed ID: 16158957
[TBL] [Abstract][Full Text] [Related]
33. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
Astor M; Hall EJ
Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the cytological effects of three hypoxic cell radiosensitizers.
Spunberg JJ; Geard CR; Rutledge-Freeman MH
Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1207-15. PubMed ID: 6214532
[TBL] [Abstract][Full Text] [Related]
35. TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer.
Kasai S; Nagasawa H; Kuwasaka H; Oshodani T; Nishioka A; Ogawa Y; Yoshida S; Inayama S; Inomata T; Hori H
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):799-802. PubMed ID: 9845099
[TBL] [Abstract][Full Text] [Related]
36. Ocular absorption and toxicity of a radiosensitizer and its effect on hypoxic cells.
Rootman J; Josephy PD; Adomat H; Palcic B
Arch Ophthalmol; 1982 Mar; 100(3):468-71. PubMed ID: 7199901
[TBL] [Abstract][Full Text] [Related]
37. Further studies on toxic and radiosensitizing properties of ruthenium complexes of 4-nitroimidazoles.
Chan PK; Skov KA; James BR
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):49-55. PubMed ID: 3496310
[TBL] [Abstract][Full Text] [Related]
38. Studies on the toxicity of RSU-1069.
Whitmore GF; Gulyas S
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1219-22. PubMed ID: 3755716
[TBL] [Abstract][Full Text] [Related]
39. Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.
Asquith JC; Watts ME; Patel K; Smithen CE; Adams GE
Radiat Res; 1974 Oct; 60(1):108-18. PubMed ID: 10881704
[No Abstract] [Full Text] [Related]
40. Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro.
Sadeghi N; Kok RJ; Bos C; Zandvliet M; Geerts WJC; Storm G; Moonen CTW; Lammers T; Deckers R
Nanotechnology; 2019 Jun; 30(26):264001. PubMed ID: 30836341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
